Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.

By S. Tsimikas, E. Brilakis, E. Miller, J. Mcconnell, R. Lennon, K. Kornman, J. Witztum, P. Berger. New England Journal of Medicine, 2005

766 citations recorded by the source corpus.

Subfields: Biochemistry, Immunology, Surgery

View Paper: https://www.semanticscholar.org/paper/5151c88f59c12e38d387fe624c3da9cffe635428

Citations in the corpus

• Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality (2009, neutral): “Similarly, larger studies are needed to assess proposed synergy in the promotion of vascular disease through oxidative damage (again, this was not possible in the current study because the data set lacked concomitant information on oxidized LDL and lipoprotein-associated phospholipase A2).(99-101)”